UPECLIN HC FM Botucatu Unesp
unesp.brTotal trials
64
Active
3
Phase 3
4
Total enrollment
9,907
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| CELULAS TRONCO | — | — | — | — | — | 1 |
Next readouts
- 2028-03-31
Top conditions
- HIV Infections5
- Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted3
- Stroke2
- Chronic Obstructive Pulmonary Disease2
- Telangiectasis2
- Covid192
- Patients in Good Health2
- Varicose Veins2
Frequently asked questions about UPECLIN HC FM Botucatu Unesp
- How many clinical trials does UPECLIN HC FM Botucatu Unesp have on ClinicalTrials.gov?
- UPECLIN HC FM Botucatu Unesp is listed as the lead sponsor on 64 clinical trials in ClinicalTrials.gov, 3 of which are currently active (recruiting, enrolling, or ongoing).
- How many of UPECLIN HC FM Botucatu Unesp's trials are in Phase 3?
- 4 of UPECLIN HC FM Botucatu Unesp's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does UPECLIN HC FM Botucatu Unesp focus on?
- UPECLIN HC FM Botucatu Unesp's most-studied conditions on ClinicalTrials.gov are HIV Infections, Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted, Stroke, Chronic Obstructive Pulmonary Disease, Telangiectasis.
- When are UPECLIN HC FM Botucatu Unesp's next clinical trial readouts?
- UPECLIN HC FM Botucatu Unesp has 1 upcoming primary-completion readout tracked here; the soonest is “Cell Therapy for Lower Limb Ulcers in Patients With Critical Limb Ischemia”, expected around 2028-03-31.